Share
2,329 Posts.
lightbulb Created with Sketch. 20
clock Created with Sketch.
17/12/15
11:54
Share
Originally posted by tootip
↑
I do hope so.
Why the poison pill 2 years ago ? . shows that they knew they are a target.
taking it to fda approval without a buyout / partnership
in this time , multiple markets are open for cpulse2
cpulse 2 development
last offering was 10.5 , reason we fell from these highs was the slow enrollment trial start.
the pause ofcourse was a kick in the balls and the time it took for reactivation took us from 4s to 1
has the technology changed ? is their a competitor ? no
finance situation / enrollments
finance : debt ammended . 8 months of cash ? why would svb agree unless they know something is in the offing. the company has 2 options , major dilution at these levels ( they lose out the most ) or a partnership or us distribution rights or a license deal. that would give us enough money to last 2016.
have an offering of 6-7m shares when the stock is $6-10
enrollments : 40 sites soon to be all activated. the only way is up
cpulse2 : talks with the fda to fast track approval
-----------------------------------------------------------------------------------------------------------
but the questions are
1- why are we at $1 and no major buying
2- why is the company silent 3 weeks after ceo sudden departure
3- how are we valued at $24m ?
4- till when will we have positive news and the stock drops ( debt ammendment )
5- 91% down since nasdaq inception.
are we the only ones who see the potential ?
is there something hidden which explains the death of the stock
we sound like a broken cd , but the more these questions are left un answered , the further we will drop
the more we drop , the harder it will be for the company to achieve its goals.
Expand
Tootip on this thread we are looking at the macro view, sick of navel gazing time to be a visionary.